Lucid Ret. on assets
What is the Ret. on assets of Lucid?
The Ret. on assets of Lucid, Inc. is -174.77%
What is the definition of Ret. on assets?
Return on assets indicates how profitable a company’s assets are in generating revenue. It is computed by dividing net income by average total assets.
ttm (trailing twelve months)
The return on assets (ROA) tells you what the company can do with what it has, i.e. how many dollars of earnings they derive from each dollar of assets they control. It's a useful number for comparing competing companies in the same industry. The number will vary widely across different industries. Return on assets gives an indication of the capital intensity of the company, which will depend on the industry; companies that require large initial investments will generally have lower return on assets. ROAs over 5% are generally considered good.
Ret. on assets of companies in the Health Care sector on OTC compared to Lucid
What does Lucid do?
Caliber Imaging & Diagnostics, Inc., a medical technologies company, designs, develops, and markets imaging solutions that shows tissue at the cellular level in the United States. The company provides VivaScope 1500, a reflectance confocal imaging system that enables clinicians and researchers to capture confocal images that depict cellular structures of living tissue; and VivaScope 3000, a hand-held in vivo reflectance confocal microscope for skin imaging. It also offers VivaScan software to schedule patients for examinations, perform imaging examinations on one or more lesions during a visit, review, and report on images obtained during an examination, as well as VivaNet, a digital telepathology system. The company was formerly known as Lucid, Inc. and changed its name to Caliber Imaging & Diagnostics, Inc. in August 2012. Caliber Imaging & Diagnostics, Inc. was founded in 1991 and is headquartered in Andover, Massachusetts.
Companies with ret. on assets similar to Lucid
- Hank Payments has Ret. on assets of -178.17%
- Adveritas has Ret. on assets of -177.51%
- Rhinomed has Ret. on assets of -176.99%
- Mydecine Innovations has Ret. on assets of -176.15%
- Achiko AG has Ret. on assets of -175.93%
- Power Projects has Ret. on assets of -174.85%
- Lucid has Ret. on assets of -174.77%
- Biostage has Ret. on assets of -174.42%
- Hepion Pharmaceuticals Inc has Ret. on assets of -174.30%
- Bankers Cobalt Corp has Ret. on assets of -174.28%
- LawFinance has Ret. on assets of -174.20%
- Pathway Health Corp has Ret. on assets of -173.40%
- Harvest Technology has Ret. on assets of -172.87%